Saturday, November 22, 2008 - 10:24AM EST

General Interest Articles

21. Treatment-resistant schizophrenia.

Author
Elkis H;
Institution
Department and Institute of Psychiatry, University of Sao Paulo Medical School (FMUSP), Sao Paulo, SP, Brazil. helkis@usp.br <helkis@usp.br>
Journal
Psychiatr Clin North Am. 2007 Sep;30(3):511-33.
Abstract URL
Click here to view abstract

22. Rehabilitation and recovery in schizophrenia.

Author
Velligan DI; Gonzalez JM;
Institution
Department of Psychiatry, Division of Schizophrenia and Related Disorders-MSC 7792, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. velligand@uthscsa.edu <velligand@uthscsa.edu>
Journal
Psychiatr Clin North Am. 2007 Sep;30(3):535-48.
Abstract URL
Click here to view abstract

23. Families and schizophrenia: the view from advocacy.

Author
Huey LY; Lefley HP; Shern DL; Wainscott CA;
Institution
Department of Psychiatry, University of Connecticut Health Center, School of Medicine, Farmington, CT 06030-1410, USA. huey@psychiatry.uchc.edu <huey@psychiatry.uchc.edu>
Journal
Psychiatr Clin North Am. 2007 Sep;30(3):549-66.
Abstract URL
Click here to view abstract

24. Recovery and systems transformation for schizophrenia.

Author
Peebles SA; Mabe PA; Davidson L; Fricks L; Buckley PF; Fenley G;
Institution
Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA. speebles@mcg.edu <speebles@mcg.edu>
Journal
Psychiatr Clin North Am. 2007 Sep;30(3):567-83.
Abstract URL
Click here to view abstract

25. Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.

Author
Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W; Schimmelmann BG; Lambert M;
Institution
Medical Department, Child and Adolescent Psychiatry, Lilly Deutschland, Saalburgstr. 153, 61350 Bad Homburg, Germany.
Journal
J Psychiatr Res. 2007 Aug 24;.
Abstract URL
Click here to view abstract

26. Substance abuse and the management of medication nonadherence in schizophrenia.

Author
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M;
Institution
American Psychiatric Institute for Research and Education, Arlington, Virginia, USA.
Journal
J Nerv Ment Dis. 2006 Jun;194(6):454-7.
Abstract URL
Click here to view abstract

27. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.

Author
Tiihonen J; Walhbeck K; Lonnqvist J; Klaukka T; Ioannidis JP; Volavka J; Haukka J;
Institution
Department of Forensic Psychiatry, University of Kuopio, Niuvanniemi Hospital, FIN-70240 Kuopio, Finland. jari.tiihonen@niuva.fi
Journal
BMJ. 2006 Jul 29;333(7561):224. Epub 2006 Jul 6.
Abstract URL
Click here to view abstract

28. Medication-induced weight gain and dyslipidemia in patients with schizophrenia.

Author
Fenton WS; Chavez MR;
Institution
Division of Adult Trasnlation Reserach and Treatment Development, NIMH, Bethesda, MD, USA.
Journal
Am J Psychiatry. 2006 Oct;163(10):1697-704; quiz 1858-9.

29. Practices preventing rehospitalization of individuals with schizophrenia.

Author
Prince JD;
Institution
Rutgers: The State University of New Jersey, School of Social Work, New Brunswick, New Jersey 08901-1167, USA.
Journal
J Nerv Ment Dis. 2006 Jun;194(6):397-403.
Abstract URL
Click here to view abstract

30. Understanding the glass ceiling for functional outcome in schizophrenia.

Author
Carter CS;
Institution
Journal
Am J Psychiatry. 2006 Mar;163(3):356-8.
Pages: 1 2 3 4